Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent or Persistent Endometrial Carcinoma
NCT00377520Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in endometrial carcinoma, sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00377520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377520.